Craig A Collard insider trades
Open-market stock purchases and sales by Craig A Collard, Chief Executive Officer at Heron Therapeutics, Inc /de/, from SEC Form 4 filings since Mar 3, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Oct 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Sold (not open market) | $1.2K |
| Oct 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jun 24, 2026 | TSNDF TerrAscend Corp | Sold (not open market) | $966K |
| Jun 24, 2026 | TSNDF TerrAscend Corp | Bought (not open market) | $39K |
| Apr 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 3, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Oct 31, 2025 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
Companies traded
- HRTX Heron Therapeutics, Inc /de/: 1 buy, last Oct 19, 2026
- TSNDF TerrAscend Corp: other filings, last Jun 24, 2026
- TRSSF TerrAscend Corp: 2 buys, last Jun 22, 2023
- OPNT Opiant Pharmaceuticals, Inc: 6 buys, last Mar 2, 2023
- SRRA Sierra Oncology, Inc: 2 buys, last Jul 1, 2022
- CRTX Cornerstone Therapeutics Inc: 2 sales, last Feb 3, 2014